These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31971004)

  • 21. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban.
    Eche IM; Elsamadisi P; Wex N; Wyers MC; Brat GA; Cunningham K; Bauer KA
    Pharmacotherapy; 2019 Aug; 39(8):861-865. PubMed ID: 31251821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.
    Nafee T; Aslam A; Chi G; Pahlavani S; Nimri D; Kuchkuntla AR; Talib U; Michalak N; Daaboul Y; Korjian S; Gallo A; Gibson CM
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):237-245. PubMed ID: 28282497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Andexanet Alfa for Reversing Factor Xa Inhibition.
    Sible AM; Nawarskas JJ
    Cardiol Rev; 2019; 27(2):108-111. PubMed ID: 30362966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban.
    Abuan I; Wong KH; Bolinske B; Hale KS
    J Pharm Technol; 2019 Jun; 35(3):119-125. PubMed ID: 34860981
    [No Abstract]   [Full Text] [Related]  

  • 25. [Andexanet alfa: the best antidote for factor Xa inhibitors?].
    Klok FA; Huisman MV
    Ned Tijdschr Geneeskd; 2019 Jun; 163():. PubMed ID: 31283119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
    Tummala R; Kavtaradze A; Gupta A; Ghosh RK
    Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.
    Siddiqui F; Tafur A; Bontekoe E; Iqbal O; Jeske W; Mehrotra S; Hoppensteadt D; Ramacciotti E; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619895120. PubMed ID: 31914798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
    Connolly SJ; Milling TJ; Eikelboom JW; Gibson CM; Curnutte JT; Gold A; Bronson MD; Lu G; Conley PB; Verhamme P; Schmidt J; Middeldorp S; Cohen AT; Beyer-Westendorf J; Albaladejo P; Lopez-Sendon J; Goodman S; Leeds J; Wiens BL; Siegal DM; Zotova E; Meeks B; Nakamya J; Lim WT; Crowther M;
    N Engl J Med; 2016 Sep; 375(12):1131-41. PubMed ID: 27573206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA.
    Heo YA
    Drugs Ther Perspect; 2018; 34(11):507-512. PubMed ID: 30459509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum.
    Cuker A; Burnett A; Triller D; Crowther M; Ansell J; Van Cott EM; Wirth D; Kaatz S
    Am J Hematol; 2019 Jun; 94(6):697-709. PubMed ID: 30916798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The authors reply: Still much to learn about andexxa alfa in the ED.
    Brown CS; Scott RA; Sridharan M; Rabinstein AA
    Am J Emerg Med; 2020 Apr; 38(4):827-828. PubMed ID: 32024592
    [No Abstract]   [Full Text] [Related]  

  • 32. Andexanet alfa for the reversal of factor Xa inhibitors.
    Favresse J; Hardy M; van Dievoet MA; Sennesael AL; Douxfils J; Samama CM; Vornicu O; Dincq AS; Lessire S; Mullier F
    Expert Opin Biol Ther; 2019 May; 19(5):387-397. PubMed ID: 30974977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage.
    Micieli A; Demchuk AM; Wijeysundera HC
    Stroke; 2021 Apr; 52(4):1390-1397. PubMed ID: 33641387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of agents for reversing the effects of target-specific oral anticoagulants.
    Riley TR; Gauthier-Lewis ML; Sanchez CK; Douglas JS
    Am J Health Syst Pharm; 2017 Jan; 74(2):54-61. PubMed ID: 27895055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world utilization of andexanet alfa.
    Brown CS; Scott RA; Sridharan M; Rabinstein AA
    Am J Emerg Med; 2020 Apr; 38(4):810-814. PubMed ID: 31870672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor-associated major bleeding.
    Kimpton M; Siegal DM
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):204-208. PubMed ID: 31808849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
    Anderson JL; Heidenreich PA; Barnett PG; Creager MA; Fonarow GC; Gibbons RJ; Halperin JL; Hlatky MA; Jacobs AK; Mark DB; Masoudi FA; Peterson ED; Shaw LJ
    J Am Coll Cardiol; 2014 Jun; 63(21):2304-22. PubMed ID: 24681044
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.
    Milling TJ; Ziebell CM
    Trends Cardiovasc Med; 2020 Feb; 30(2):86-90. PubMed ID: 30952383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.
    January CT; Wann LS; Calkins H; Chen LY; Cigarroa JE; Cleveland JC; Ellinor PT; Ezekowitz MD; Field ME; Furie KL; Heidenreich PA; Murray KT; Shea JB; Tracy CM; Yancy CW
    Circulation; 2019 Jul; 140(2):e125-e151. PubMed ID: 30686041
    [No Abstract]   [Full Text] [Related]  

  • 40. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.